One in nine people may be able to control their viral load after stopping treatment, US study finds
Zero transmissions mean zero risk – PARTNER 2 study results announced
Age difference in HIV infection matters – but it’s not always the younger person who is at risk
Darunavir/ritonavir most durable boosted protease inhibitor in European patients, especially those switching treatment for any reason
Faster action on adherence is needed after viral load becomes detectable, researchers warn global treatment programmes
Baseline CD4 count biggest factor in long-term immune system improvements after starting HIV therapy
HIV-positive children in resource-limited settings can achieve good virological outcomes without routine viral load or CD4 cell count monitoring
Schistosomiasis increases risk of infection with HIV, especially for women and is also associated with a higher HIV viral load
Virally suppressed people have “effectively no risk” of transmitting HIV, says US CDC: but how many are suppressed?
